摘要
背景:基本helix-loop-helix(bHLH)蛋白家族是一类转录因子,它们与细胞增殖有关,组织分化,以及其他重要的开发过程。我们报道,核本地化蛋白1(Nulp1)可能作为小说bHLH转录因子调节细胞功能。但是,它在发展中的作用体内仍然未知。 方法:Nulp1(dNulp1)突变体是由CRISPR / Cas9针对未知函数的域(DUF654)的C末端。Wg目标基因的表达分析中存在。我们使用Top-Flash荧光素酶记者分析应对Wg信号。 结果:在这里,我们表明,果蝇Nulp1(dNulp1)突变体,由CRISPR / Cas9针对未知函数的域(DUF654)的C末端,部分纯合子的致命的和罕见的幸免型股骨弯曲,类似于先天性bent-bone发育不良的主要表现在人类Stuve——Weidemann综合症。苍蝇表型可以获救dNulp1表达,表明dNulp1飞股骨发展和生存至关重要。此外,dNulp1过度抑制造成的切口翼表型过度sgg / GSK3β规范化Wnt级联的抑制剂。此外,存在积极分析显示,七个目标基因受Wg信号通路抑制在响应dNulp1击倒,而两个负监管工作组目标上调dNulp1突变体。最后,dNulp1超表达显著激活Top-Flash Wnt信号记者。 结论:bHLH蛋白质dNulp1股骨发展和生存至关重要的果蝇作为一个积极的辅助因子在Wnt /无翼的信号。
关键词: bHLH、dNulp1 CRISPR / Cas9 Wnt / Wg信号
Current Molecular Medicine
Title:The bHLH Protein Nulp1 is Essential for Femur Development Via Acting as a Cofactor in Wnt Signaling in Drosophila
Volume: 17 Issue: 7
关键词: bHLH、dNulp1 CRISPR / Cas9 Wnt / Wg信号
摘要: Background: The basic helix-loop-helix (bHLH) protein families are a large class of transcription factors, which are associated with cell proliferation, tissue differentiation, and other important development processes. We reported that the Nuclear localized protein-1 (Nulp1) might act as a novel bHLH transcriptional factor to mediate cellular functions. However, its role in development in vivo remains unknown.
Methods: Nulp1 (dNulp1) mutants are generated by CRISPR/Cas9 targeting the Domain of Unknown Function (DUF654) in its C terminal. Expression of Wg target genes are analyzed by qRT-PCR. We use the Top-Flash luciferase reporter assay to response to Wg signaling.
Results: Here we show that Drosophila Nulp1 (dNulp1) mutants, generated by CRISPR/Cas9 targeting the Domain of Unknown Function (DUF654) in its C terminal, are partially homozygous lethal and the rare escapers have bent femurs, which are similar to the major manifestation of congenital bent-bone dysplasia in human Stuve- Weidemann syndrome. The fly phenotype can be rescued by dNulp1 over-expression, indicating that dNulp1 is essential for fly femur development and survival. Moreover, dNulp1 overexpression suppresses the notch wing phenotype caused by the overexpression of sgg/GSK3β, an inhibitor of the canonical Wnt cascade. Furthermore, qRT-PCR analyses show that seven target genes positively regulated by Wg signaling pathway are down-regulated in response to dNulp1 knockout, while two negatively regulated Wg targets are up-regulated in dNulp1 mutants. Finally, dNulp1 overexpression significantly activates the Top-Flash Wnt signaling reporter.
Conclusion: We conclude that bHLH protein dNulp1 is essential for femur development and survival in Drosophila by acting as a positive cofactor in Wnt/Wingless signaling.
Export Options
About this article
Cite this article as:
The bHLH Protein Nulp1 is Essential for Femur Development Via Acting as a Cofactor in Wnt Signaling in Drosophila, Current Molecular Medicine 2017; 17 (7) . https://dx.doi.org/10.2174/1566524018666180212145714
DOI https://dx.doi.org/10.2174/1566524018666180212145714 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Steroids in ARDS and Sepsis: Is it Time for a Comeback?]
Current Respiratory Medicine Reviews Anticoagulant Therapy During Pregnancy for Maternal and Fetal Acquired and Inherited Thrombophilia
Current Medicinal Chemistry Inhibitors of HIV-1 Protease: Current State of the Art 10 Years After their Introduction. From Antiretroviral Drugs to Antifungal, Antibacterial and Antitumor Agents Based on Aspartic Protease Inhibitors
Current Medicinal Chemistry Role of C-Type Lectins in Mycobacterial Infections
Current Drug Targets Epigenomic-Basis of Preemptive Medicine for Neurodevelopmental Disorders
Current Genomics Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia
Current Molecular Pharmacology Toward a Discipline of Pharmacoepigenomics
Current Pharmacogenomics Inhaled Dry Powder Formulations for Treating Tuberculosis
Current Drug Delivery HIV-1 Reverse Transcriptase: A Therapeutical Target in the Spotlight
Current Medicinal Chemistry Electronic Recording of Growth Hormone Dosing History: The Easypod™ Auto-Injector
Current Drug Therapy Peptide Self-Assemblies for Drug Delivery
Current Topics in Medicinal Chemistry Current Status of Epigenetics and Anticancer Drug Discovery
Anti-Cancer Agents in Medicinal Chemistry Cholesterol Homeostasis Failure in the Brain: Implications for Synaptic Dysfunction and Cognitive Decline
Current Medicinal Chemistry Targeting ADAM17 Sheddase Activity in Cancer
Current Drug Targets Mitochondrial Mechanisms of Metabolic Reprogramming in Proliferating Cells
Current Medicinal Chemistry Interaction between Microbes and Host Intestinal Health: Modulation by Dietary Nutrients and Gut-Brain-Endocrine-Immune Axis
Current Protein & Peptide Science Cardioprotection by Regular Ethanol Consumption: Potential Mechanisms and Clinical Application
Current Drug Abuse Reviews Adenoviral Gene Delivery for HIV-1 Vaccination
Current Gene Therapy The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21)
Current Protein & Peptide Science Present and Future of Tyrosine Kinase Inhibitors in Renal Cell Carcinoma: Analysis of Hematologic Toxicity
Recent Patents on Anti-Infective Drug Discovery